This federal contract award is for the pharmaceutical product Envarsus XR 4 mg tablet, valued at $1,615.33, and was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order with a firm fixed price, and the ultimate completion date is November 25, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for supplying a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs, including those serving military personnel and veterans.
Generated 1/31/25, 9:12 AM